메뉴 건너뛰기




Volumn 64, Issue 10, 2015, Pages 3406-3412

Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEMOGLOBIN A1C; PLACEBO; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PEPTIDE; VENOM;

EID: 85047289216     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1718     Document Type: Article
Times cited : (52)

References (21)
  • 2
    • 84856000294 scopus 로고    scopus 로고
    • GLP-1, the gut-brain, and brain-periphery axes
    • Cabou C, Burcelin R. GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud 2011;8:418-431
    • (2011) Rev Diabet Stud , vol.8 , pp. 418-431
    • Cabou, C.1    Burcelin, R.2
  • 3
    • 13644268431 scopus 로고    scopus 로고
    • The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem
    • Alvarez E, Martínez MD, Roncero I, et al. The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 2005;92:798-806
    • (2005) J Neurochem , vol.92 , pp. 798-806
    • Alvarez, E.1    Martínez, M.D.2    Roncero, I.3
  • 4
    • 79952310049 scopus 로고    scopus 로고
    • Secretion of glucagonlike peptide-1 (GLP-1) in type 2 diabetes: What is up, what is down?
    • Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagonlike peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10-18
    • (2011) Diabetologia , vol.54 , pp. 10-18
    • Nauck, M.A.1    Vardarli, I.2    Deacon, C.F.3    Holst, J.J.4    Meier, J.J.5
  • 5
    • 84878808238 scopus 로고    scopus 로고
    • Pharmacology, physiology, and mechanisms of incretin hormone action
    • Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 2013;17:819-837
    • (2013) Cell Metab , vol.17 , pp. 819-837
    • Campbell, J.E.1    Drucker, D.J.2
  • 6
    • 0036198285 scopus 로고    scopus 로고
    • Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    • Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J Mol Neurosci 2002;18:7-14
    • (2002) J Mol Neurosci , vol.18 , pp. 7-14
    • Kastin, A.J.1    Akerstrom, V.2    Pan, W.3
  • 7
    • 48449093468 scopus 로고    scopus 로고
    • Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
    • Muscelli E, Mari A, Casolaro A, et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 2008;57:1340-1348
    • (2008) Diabetes , vol.57 , pp. 1340-1348
    • Muscelli, E.1    Mari, A.2    Casolaro, A.3
  • 8
    • 84871564295 scopus 로고    scopus 로고
    • Direct effect of GLP-1 infusion on endogenous glucose production in humans
    • Seghieri M, Rebelos E, Gastaldelli A, et al. Direct effect of GLP-1 infusion on endogenous glucose production in humans. Diabetologia 2013;56:156-161
    • (2013) Diabetologia , vol.56 , pp. 156-161
    • Seghieri, M.1    Rebelos, E.2    Gastaldelli, A.3
  • 9
    • 84858713174 scopus 로고    scopus 로고
    • Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
    • Hunter K, Hölscher C. Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 2012;13:33
    • (2012) BMC Neurosci , vol.13 , pp. 33
    • Hunter, K.1    Hölscher, C.2
  • 10
    • 0037349072 scopus 로고    scopus 로고
    • Entry of exendin-4 into brain is rapid but may be limited at high doses
    • Kastin AJ, Akerstrom V. Entry of exendin-4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 2003;27:313-318
    • (2003) Int J Obes Relat Metab Disord , vol.27 , pp. 313-318
    • Kastin, A.J.1    Akerstrom, V.2
  • 11
    • 84885977398 scopus 로고    scopus 로고
    • Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity
    • Schlögl H, Kabisch S, Horstmann A, et al. Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity. Diabetes Care 2013;36:1933-1940
    • (2013) Diabetes Care , vol.36 , pp. 1933-1940
    • Schlögl, H.1    Kabisch, S.2    Horstmann, A.3
  • 12
    • 40749107089 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 inhibits bloodbrain glucose transfer in humans
    • Lerche S, Brock B, Rungby J, et al. Glucagon-like peptide-1 inhibits bloodbrain glucose transfer in humans. Diabetes 2008;57:325-331
    • (2008) Diabetes , vol.57 , pp. 325-331
    • Lerche, S.1    Brock, B.2    Rungby, J.3
  • 13
    • 84870624506 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia
    • Gejl M, Egefjord L, Lerche S, et al. Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia. J Cereb Blood Flow Metab 2012;32:2146-2152
    • (2012) J Cereb Blood Flow Metab , vol.32 , pp. 2146-2152
    • Gejl, M.1    Egefjord, L.2    Lerche, S.3
  • 15
    • 0032856158 scopus 로고    scopus 로고
    • Altered hypothalamic function in response to glucose ingestion in obese humans
    • Matsuda M, Liu Y, Mahankali S, et al. Altered hypothalamic function in response to glucose ingestion in obese humans. Diabetes 1999;48:1801-1806
    • (1999) Diabetes , vol.48 , pp. 1801-1806
    • Matsuda, M.1    Liu, Y.2    Mahankali, S.3
  • 16
    • 10244241840 scopus 로고    scopus 로고
    • Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake
    • Navarro M, Rodriquez de Fonseca F, Alvarez E, et al. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J Neurochem 1996;67:1982-1991
    • (1996) J Neurochem , vol.67 , pp. 1982-1991
    • Navarro, M.1    Rodriquez De Fonseca, F.2    Alvarez, E.3
  • 17
    • 0347360368 scopus 로고    scopus 로고
    • Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose
    • Yang XJ, Kow LM, Pfaff DW, Mobbs CV. Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes 2004;53:67-73
    • (2004) Diabetes , vol.53 , pp. 67-73
    • Yang, X.J.1    Kow, L.M.2    Pfaff, D.W.3    Mobbs, C.V.4
  • 18
    • 84920367212 scopus 로고    scopus 로고
    • Glucokinase activity in the arcuate nucleus regulates glucose intake
    • Hussain S, Richardson E, Ma Y, et al. Glucokinase activity in the arcuate nucleus regulates glucose intake. J Clin Invest 2015;125:337-349
    • (2015) J Clin Invest , vol.125 , pp. 337-349
    • Hussain, S.1    Richardson, E.2    Ma, Y.3
  • 20
    • 0032883250 scopus 로고    scopus 로고
    • No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
    • Hasselbalch SG, Knudsen GM, Videbaek C, et al. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 1999;48:1915-1921
    • (1999) Diabetes , vol.48 , pp. 1915-1921
    • Hasselbalch, S.G.1    Knudsen, G.M.2    Videbaek, C.3
  • 21
    • 0036895563 scopus 로고    scopus 로고
    • The role of insulin in human brain glucose metabolism: An 18fluoro-deoxyglucose positron emission tomography study
    • Bingham EM, Hopkins D, Smith D, et al. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002;51:3384-3390
    • (2002) Diabetes , vol.51 , pp. 3384-3390
    • Bingham, E.M.1    Hopkins, D.2    Smith, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.